Moreover, the EPHB4-CAR-T cells showed a very high antitumor effect against P3F-positive ARMS, as opposed to the limited immunomodulatory effect of P3F on RMS targeted by CAR-T cells. The gene discussed is EPHB4; the disease is alveolar rhabdomyosarcoma.